Загрузка...
Immune System, Friend or Foe of Oncolytic Virotherapy?
Oncolytic viruses (OVs) are an emerging class of targeted anticancer therapies designed to selectively infect, replicate in, and lyse malignant cells without causing harm to normal, healthy tissues. In addition to direct oncolytic activity, OVs have shown dual promise as immunotherapeutic agents. Th...
Сохранить в:
| Опубликовано в: : | Front Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5440545/ https://ncbi.nlm.nih.gov/pubmed/28589085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00106 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|